These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 35767161)
21. Gadolinium-Free Contrast Agents for Magnetic Resonance Imaging of the Central Nervous System. Gale EM; Caravan P ACS Chem Neurosci; 2018 Mar; 9(3):395-397. PubMed ID: 29431424 [TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance imaging of pulmonary ventilation. Initial experiences with a gadolinium-DTPA-based aerosol. Misselwitz B; Mühler A; Heinzelmann I; Böck JC; Weinmann HJ Invest Radiol; 1997 Dec; 32(12):797-801. PubMed ID: 9406020 [TBL] [Abstract][Full Text] [Related]
23. Dynamic contrast-enhanced MR imaging of the upper abdomen: enhancement properties of gadobutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer. Adam G; Neuerburg J; Spüntrup E; Mühler A; Scherer K; Günther RW Magn Reson Med; 1994 Nov; 32(5):622-8. PubMed ID: 7808263 [TBL] [Abstract][Full Text] [Related]
24. Gd-DTPA as a contrast agent in CT. Bloem JL; Wondergem J Radiology; 1989 May; 171(2):578-9. PubMed ID: 2704827 [TBL] [Abstract][Full Text] [Related]
25. [MRT of experimental liver abscesses: a comparison of a new blood pool contrast medium with gadolinium-DTPA in animal experiments]. Dick A; Adam G; Spüntrup E; Prescher A; Mühler A; Günther RW Rofo; 1996 Oct; 165(4):392-7. PubMed ID: 8963054 [TBL] [Abstract][Full Text] [Related]
26. Region of Interest Selection in Nonclinical Studies of Accumulated Gadolinium-based Contrast Agent-induced T1 Hyperintensity in Deep Cerebellar Nuclei. Idée JM; Robert P; Raynaud JS; Rasschaert M; Fretellier N; Factor C; Corot C Radiology; 2018 Apr; 287(1):360-362. PubMed ID: 29558301 [No Abstract] [Full Text] [Related]
27. Magnetization transfer contrast in Gd-DTPA-enhanced imaging of brain tumors. Niemi P; Kurki T; Lundbom N; Kormano M Invest Radiol; 1991 Nov; 26 Suppl 1():S248-9; discussion S253-4. PubMed ID: 1808140 [No Abstract] [Full Text] [Related]
29. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid. Lin CY; Chang WC; Chou CT; Chen RC J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453 [TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance imaging of the pancreas with gadolinium-DTPA. Chezmar JL; Nelson RC; Small WC; Bernardino ME Gastrointest Radiol; 1991; 16(2):139-42. PubMed ID: 2016027 [TBL] [Abstract][Full Text] [Related]
31. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA]. Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470 [TBL] [Abstract][Full Text] [Related]
32. Simple method for quantification of gadolinium magnetic resonance imaging contrast agents using ESR spectroscopy. Takeshita K; Kinoshita S; Okazaki S Chem Pharm Bull (Tokyo); 2012; 60(1):31-6. PubMed ID: 22223372 [TBL] [Abstract][Full Text] [Related]
33. Gadolinium retention and clearance after administration of macrocyclic magnetic resonance contrast agents to rats. Bussi S; Maisano F; Tedoldi F; Kirchin MA Pediatr Radiol; 2019 Jul; 49(8):1110-1111. PubMed ID: 31254022 [No Abstract] [Full Text] [Related]
34. Notes on "Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent". Runge VM AJR Am J Roentgenol; 2008 Jun; 190(6):1433-4. PubMed ID: 18492887 [No Abstract] [Full Text] [Related]
35. [Gadolinium-DTPA as an oral contrast medium for magnetic resonance tomography of the pancreas]. Neumann K; Kaminsky S; Gogoll M; Clauss W; Langer M; Felix R Rofo; 1991 Mar; 154(3):262-8. PubMed ID: 1849293 [TBL] [Abstract][Full Text] [Related]
36. Facilitated magnetic resonance imaging diagnosis of pulmonary disease using a macromolecular blood-pool contrast agent, polylysine-(Gd-DTPA)40. Brasch RC; Berthezene Y; Vexler VS; Moseley M; Clément O; Muehler A; Price D; Jerome H Invest Radiol; 1991 Nov; 26 Suppl 1():S42-5; discussion S60-4. PubMed ID: 1808147 [No Abstract] [Full Text] [Related]
37. Giant extra-adrenal pheochromocytoma: magnetic resonance imaging with gadolinium-DTPA enhancement. Terk MR; de Verdier H; Colletti PM Magn Reson Imaging; 1993; 11(1):47-50. PubMed ID: 8423721 [TBL] [Abstract][Full Text] [Related]
38. Residual or Retained Gadolinium. Ben Salem D; Ognard J; Guiu B Radiology; 2016 Nov; 281(2):650-651. PubMed ID: 27755932 [No Abstract] [Full Text] [Related]
39. Magnetic resonance imaging contrast agents. Design and physicochemical properties of gadodiamide. Chang CA Invest Radiol; 1993 Mar; 28 Suppl 1():S21-7. PubMed ID: 8486500 [No Abstract] [Full Text] [Related]
40. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging. Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]